MWM
MRNA icon

Marietta Wealth Management’s Moderna MRNA Stock Holding History

Marietta Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-19,616
Closed -$2.03M – 103
2023
Q3 		$2.03M Buy
19,616
+1,239
+7% +$138K 0.4% 79
2023
Q2 		$2.23M Buy
18,377
+5,477
+42% +$731K 0.42% 80
2023
Q1 		$1.98M Buy
+12,900
New +$2.13M 0.42% 76

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Marietta Wealth Management's MRNA Position: Q4 2023 in Review

Marietta Wealth Management sold out of Moderna (MRNA) in Q4 2023, closing a stake of 19,616 shares — an estimated $2.03M sold.

Marietta Wealth Management first reported a position in MRNA in Q1 2023 and held it in 3 quarters. The position peaked at $2.23M in Q2 2023. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Marietta Wealth Management reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Marietta Wealth Management sold 19,616 Moderna shares in Q4 2023, an estimated $2.03M.
  • Marietta Wealth Management first reported a position in Moderna in Q1 2023 and held it in 3 quarters.
  • Marietta Wealth Management's Moderna position peaked at $2.23M in Q2 2023.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Marietta Wealth Management's 13F filing for Q4 2023, filed 30 Jan 2024.